New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
10:40 EDTWEN, CTAS, SFLY, AOL, SNYHigh option volume stocks: CTAS SNY SFLY WEN AOL
News For CTAS;SNY;SFLY;WEN;AOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
13:17 EDTAOLAOL sinks after downgrade, report of no Yahoo interest
Shares of AOL (AOL) are falling after Wells Fargo downgraded the stock to Market Perform from Outperform and CNBC’s David Faber reported that Yahoo has ruled out a potential acquisition of the company. WHAT'S NEW: AOL is likely to encounter increased competition in Internet video advertising, in the wake of acquisitions by Facebook (FB) and Yahoo (YHOO), Wells contended in a note to investors earlier today. Specifically, Facebook's acquisition of Liverail will enable the social network to improve the targeting of its video ads, while Yahoo is using its sales force to find buyers for the video assets of Brightroll, which Yahoo acquired. AOL is also encountering increased competition for internet video ad spending from Google's YouTube, Wells believes. Meanwhile, AOL, along with other Google search partners, may find it more difficult to maintain its current share of queries as more searches are conducted on mobile device, the firm stated. The superior functionality of Google's mobile web and app base search, along with the default search position that Google enjoys on Android devices, create headwinds for AOL and its peers, the firm stated. Wells cut its valuation range on AOL to $49-$51 from $55-$$57. WHAT'S NOTABLE: Activist investor Starboard Value has called on Yahoo to explore the possibility of combining with AOL. CNBC's David Faber, however, after speaking last night with Yahoo CEO Marissa Mayer, reported that the search giant has ruled out a potential acquisition of AOL. The interview followed Yahoo’s fourth quarter results and announcement that it would carry out a tax free spin-off of its remaining stake in Chinese e-commerce giant Alibaba (BABA). PRICE ACTION: In mid-afternoon trading, AOL fell 8% to $44, while yahoo rose 2% to $49.
09:59 EDTAOLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:31 EDTAOLAOL downgraded on rising competition at Wells Fargo
Subscribe for More Information
05:30 EDTAOLAOL downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
January 27, 2015
12:45 EDTAOLEarnings Preview: Yahoo may announce Alibaba plans with Q4 earnings
Yahoo (YHOO) is expected to report fourth quarter earnings after the market close on Tuesday, January 27 with a conference call scheduled for 5:00 pm ET. Yahoo is a digital media company that provides properties and services such as Yahoo! Search and Yahoo! News. EXPECTATIONS: Analysts are looking for earnings per share of 29c on revenue of $1.19B. The consensus range is 17c-57c for EPS, and $1.16B-$1.22B for revenue, according to First Call. LAST QUARTER: Yahoo reported Q3 EPS 52c against estimates of 30c on revenue ex-tac of $1.09B against estimates of $1.04B. The company reported Q3 GAAP display revenue down 5% to $447M and Q3 AAP search revenue up 4% to $452M. Looking ahead, Yahoo expected Q4 revenue ex-TAC $1.14B-$1.18B, Q4 non-GAAP net income $190M-$230M, and Q4 adjusted EBITDA $340M-$380M. Yahoo also said Tumblr monthly active users exceeds 1B, up 6% vs. last year. In regards to the Alibaba (BABA) sale, Yahoo expected taxes of $3.3B in Q1. NEWS: In the past quarter, Starboard and other major Yahoo supporters have voiced their support for a combination with AOL (AOL). In a letter to Yahoo's CEO and board, Starboard also said Yahoo should explore monetization for non-core minority equity investments. In a separate NY Times report, other major unnamed shareholders are collaborating to push for a merger with AOL. The Associated Press also reported that Yahoo may announce its plans for Alibaba during its Q4 earnings report. The report noted that investors hope CEO Marissa Mayer will spin off the $37B stake to ease potential taxes. Yahoo has also been rumored to be in talks to acquire a cable network. Re/code's Kara Swisher, however, said Yahoo is not buying CNN and Variety reported Yahoo has not held talks to buy Food Network from Scripps (SNI). During a Credit Suisse Technology Conference in December, Yahoo's CFO said the company's total headcount has been taken down. The company also noted that its PC display business has been challenged, but mobile is growing. IT will continue to invest in Search and is looking at new ways to monetize Flickr. STREET RESEARCH: Ahead of the Q4 earnings, BGC Financial said Yahoo is unlikely to announce a spin-out with earnings. Citigroup meanwhile believes an Alibaba spin-off will likely occur in the second half of 2015 as Yahoo begins to return to focus on its core business. Citi adds that core Yahoo is showing "green shoots "as fast growing mobile revenue become a bigger part of overall results. FBR Capital sees positive risk/reward for Yahoo shares ahead of Q4 earnings, saying expectations are low for core Yahoo business at a time when engagement is improving. PRICE ACTION: Yahoo shares have risen more than 19%, since the first day of trading following the company's Q3 report. In Tuesday afternoon trading ahead of the Q4 report, Yahoo shares are trading up 2.3%.
07:47 EDTAOLAOL Platforms technology president Amir Ashkenazi leaves company, Re/code says
Subscribe for More Information
06:13 EDTAOLAOL shutting down gaming site Joystiq, more closures to follow, Re/code says
Subscribe for More Information
January 26, 2015
09:22 EDTSFLYShutterfly estimates raised at ITG Research
Subscribe for More Information
07:11 EDTAOLAOL 'drastically' reorganizing advertising sales staff, Re/code reports
Subscribe for More Information
05:14 EDTSNYRegeneron, Sanofi announce BLA for Praluent accepted for priority review by FDA
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the Biologics License Application, or BLA, for Praluent, alirocumab. Under the Prescription Drug User Fee Act, or PDUFA, the goal for a priority review is six months, for a target action date of July 24. Alirocumab is an investigational monoclonal antibody targeting PCSK9 that is intended for the treatment of patients with hypercholesterolemia. The BLA for Praluent contains data from more than 5,000 patients, including 10 Phase 3 ODYSSEY trials. Together with additional ongoing studies including ODYSSEY OUTCOMES, the ODYSSEY clinical trial program will include more than 23,500 patients at more than 2,000 study centers in double-blind, randomized, placebo-and active-controlled trials ranging from 24 weeks to approximately 5 years. Earlier this month, the companies announced that the European Medicines Agency accepted for review the Marketing Authorization Application for Praluent in the European Union. The EMA and FDA have conditionally accepted Praluent as the trade name for alirocumab. The safety and efficacy of alirocumab have not been fully evaluated by any regulatory authority.
January 22, 2015
05:22 EDTSNYGenzyme Cerdelga granted marketing authorization by EC
Subscribe for More Information
January 21, 2015
10:16 EDTSNYLeerink biopharma analysts hold an analyst/industry conference call
Analyst Fernandez, along with Dr. Paul Gurbel and Dr. Richard Becker, discuss AstraZeneca's PEGASUS trial and the current use of Brilinta and dual antiplatelet therapy for prevention of CV disease and implications of the recently completed DAPT trial on an Analyst/Industry conference call to be held on January 21 at 1:30 pm.
January 16, 2015
13:34 EDTSFLYManning & Napier Advisors reports 5.58% passive stake in Shutterfly

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use